Chinese Traditional and Herbal Drugs
|
2025, 56(22): 8245-8257
Effect and mechanism of Renshen Guben Oral Liquid combined with Jingfang Granules on oligoasthenospermia based on proteomics
Full
ZHANG Mengdi1, GONG Liyuan1, ZHAO Wenxin1, ZHENG Chengcheng2, WANG Enli2, YAO Jingchun1,2
Affiliations
1 Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China;
2 State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Lunan Pharmaceutical Group Co., Ltd., Linyi 276005, China
doi: 10.7501/j.issn.0253-2670.2025.22.016
Outline
Objective To explore the reproductive protection effect of Renshen Guben Oral Liquid (人参固本口服液) combined with Jingfang Granules (荆防颗粒) on oligoasthenospermia mice and explore its mechanism by proteomics. Methods The mice were randomly divided into control group, model group, low, medium- and high-dose (0.1, 0.2, 0.4 mL/mice) groups of Renshen Guben Oral Liquid, Jingfang Granules (4 g/kg) group, Renshen Guben Oral Liquid (0.4 mL/mice) combined with Jingfang Granules (4 g/kg) group, with 10 mice in each group. The mouse model of oligoasthenospermia was induced by ornidazole, and the mice were sacrificed by anesthesia after 56 d of continuous modeling and administration. The number of sperm and its activity index were detected by fully automatic sperm analyzer. The pathological changes of testis and epididymis were observed by hematoxylin-eosin (HE) staining. Serum sex hormone levels in mice were detected by ELISA. The activities of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) in mouse testis were detected by micro method. Proteomics technology was used to analyze the types and expression of proteins in mouse testis, screen differentially expressed proteins and their related protein signaling pathways. The expressions of differentially expressed proteins were detected by Western blotting. Results Compared with model group, each administration group could significantly increase the number of sperm and sperm activity indexes (P < 0.05, 0.01, 0.001), significantly enhance the activity of GSH-Px in testicular tissue (P < 0.01, 0.001). Among them, Renshen Guben Oral Liquid combined with Jingfang Granules group could significantly increase the testis and epididymis indexes (P < 0.001), significantly increase the number of sperm (P < 0.01), significantly improve the pathological state of testis and epididymis, significantly callback the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2) and testosterone (T) in serum (P < 0.01, 0.001). Proteomics results showed that the therapeutic effect of Renshen Guben Oral Liquid combined with Jingfang Granules on oligoasthenospermia was mainly related to amino acid metabolism, carbon metabolism, fatty acid metabolism, peroxisome proliferator-activated receptor (PPAR) signaling pathway and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. Western blotting results showed that Renshen Guben Oral Liquid combined with Jingfang Granules could significantly increase the expression levels of p-PI3K/PI3K, p-Akt/Akt and p-mTOR/ mTOR proteins in testicular tissue (P < 0.05, 0.01). Conclusion Renshen Guben Oral Liquid combined with Jingfang Granules could synergistically treat oligoasthenospermia, increase sperm count and activity indexes, improve sex hormone disorder, oxidative stress, and reduce the pathological state of testis and epididymis. The mechanism may be related to the activation of PI3K/Akt/mTOR signaling pathway.
Renshen Guben Oral Liquid
/
Jingfang Granules
/
oligoasthenospermia
/
sex hormone disorder
/
proteomics
/
PI3K/Akt/mTOR signaling pathway
张萌迪, 巩立媛, 赵文歆, 郑成成, 王恩力, 姚景春.
基于蛋白质组学探讨人参固本口服液联合荆防颗粒对少弱精子症的影响及作用机制.
中草药,
2025
, 56
(22)
: 8245
-8257
.
DOI: 10.7501/j.issn.0253-2670.2025.22.016
ZHANG Mengdi, GONG Liyuan, ZHAO Wenxin, ZHENG Chengcheng, WANG Enli, YAO Jingchun.
Effect and mechanism of Renshen Guben Oral Liquid combined with Jingfang Granules on oligoasthenospermia based on proteomics[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(22)
: 8245
-8257
.
DOI: 10.7501/j.issn.0253-2670.2025.22.016
Year 2025 volume 56 Issue 22
44
7
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.22.016
- Receive Date:2025-08-22
- Online Date:2026-11-13